Osimertinib (AZD9291)-a science-driven, collaborative approach to rapid drug design and development
- PMID: 26961148
- DOI: 10.1093/annonc/mdw129
Osimertinib (AZD9291)-a science-driven, collaborative approach to rapid drug design and development
Comment in
-
Rociletinib: has the TIGER lost a few of its stripes?Ann Oncol. 2016 Jun;27(6):1161-1164. doi: 10.1093/annonc/mdw140. Epub 2016 Apr 4. Ann Oncol. 2016. PMID: 27045101 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
